All the Latest Game Footage and Images from Flamel's Miracle Assistant and I headed to a newly discovered Plane world for new resouces. Unfortunately, we ran into worm hole, due to which our ...

When we discovered Flamel Technologies in August 2002, it was in Wall Street's litter basket, having been dumped there in early 2002 after partner Novo Nordisk abruptly halted development on the ...

There are a few "Harry Potter" cameos in "Fantastic Beasts: The Crimes of Grindelwald" and one of them feels incredibly wasted.

Flamel has been tight-lipped in the past about the company's progress. At the time, management told shareholders the company's caginess stemmed from agreements with its partners.

As great as it would be if "Harry Potter" was real, J.K. Rowling made sure the series was distinct from real life. There's just one exception: Nicolas Flamel.

Flamel.ai, a Covington-based AI-generated content design studio, announced a $2 million pre-seed round Monday. The raise follows the company's launch last fall.

Flamel Technologies today announced that its second clinical study in healthy volunteers using its proprietary Micropump® technology applied to sodium oxybate has achieved the objective of one ...

We explore the hidden but important Harry Potter character Nicolas Flamel as he makes his movie debut in Fantastic Beasts: The Crimes of Grindelwald.

LYON, France-- (BUSINESS WIRE)-- Flamel Technologies (Nasdaq:FLML) today announced its financial results for the second quarter of 2011. Highlights during the second quarter included: Two ...

Flamel undertakes no obligation to update its forward-looking statements as a result of new information, future events or otherwise, except as required by law.

When it comes to the Fantastic Beasts franchise, some of the most exciting moments come from the connections to the Harry Potter books. Luckily for us diehard fans, The Crimes of Grindelwald ...

Flamel Technologies announced an agreement to license its Micropump technology -- a controlled release technology for the oral administration of small molecule drugs -- to GlaxoSmithKline , which ...